Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SK&F 105809

Known as: SKF-105809 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The effects of pyridinyl imidazoles, specifically SK&F 105809 and its metabolite, on normal T-cell and B-cell mediated immune… Expand
Is this relevant?
1992
1992
SK&F 105809 is a structurally novel dual inhibitor of lipoxygenase and cyclooxygenase-mediated arachidonic acid (AA) metabolism… Expand
Is this relevant?
1992
1992
Closed head injury in rats induces edema formation, which is indicated by a decrease in cerebral specific gravity and an increase… Expand
Is this relevant?
1991
1991
SK&F 105809 [2-(4-methylsulfinylphenyl)-3-(4-pyridyl)- 6,7-dihydro-[5H]-pyrrolo[1,2,a] imidazole] demonstrated unique… Expand
Is this relevant?
1991
1991
SK&F 105809 [2-(4- methylsulfinylphenyl)-3-(4-pyridyl)-6,7-dihydro-[5H]-pyrrolo[1,2- a] imidazole] was determined to be a prodrug… Expand
Is this relevant?
1991
1991
The analgetic activity of inhibitors of 5-lipoxygenase (5-LO) and cyclooxygenase (CO) was investigated using rat Randall-Selitto… Expand
Is this relevant?
1990
1990
The effects of SK&F 105809, 6,7,-dihydro-2-[4(methylsulfinyl) phenyl]-3-(4-pyridyl) -5[H]-pyrrolo[1,2-a] imidazole, on eicosanoid… Expand
Is this relevant?